Jawhar Gharbi
8PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Mar 27, 2026
The Recombinant Viral Capsid Protein rVP1 Induces Protective Immunity Against Coxsackievirus B3 (CVB3) Lethal Challenges in Balb/c Mouse Model.Manel Ben M'hadheb, Ikbel Hadj Hassine, Mohammed A Almalki
|Feb 27, 2026
Oral Immunization with the C488A Live-Attenuated Mutant of Coxsackievirus B4E2 (CVB4E2) Induces Potent Immune Response and Protects Balb/c Mice Against Lethal Infection.Jawhar Gharbi, Ikbel Hadj Hassine, Mouna Hassine
|Dec 20, 2023
Virus-like particles as powerful vaccination strategy against human viruses.Ikbel Hadj Hassine, Manel Ben M'hadheb, Mohammed A Almalki
|Jun 15, 2023
Cloning and Molecular Characterization of the Recombinant CVB4E2 Immunogenic Viral Protein (rVP1), as a Potential Subunit Protein for Vaccine and Immunodiagnostic Reagent Candidate.Ikbel Hadj Hassine, Jawhar Gharbi, Imene Amara
|Apr 28, 2023
Viral Protein VP1 Virus-like Particles (VLP) of CVB4 Induces Protective Immunity against Lethal Challenges with Diabetogenic E2 and Wild Type JBV Strains in Mice Model.Jawhar Gharbi, Ikbel Hadj Hassine, Mouna Hassine
|Oct 03, 2022
The introduction of mutations in the wild type coxsackievirus B3 (CVB3) IRES RNA leads to different levels of in vitro reduced replicative and translation efficiencies.Jawhar Gharbi, Mohammed A Almalki, Manel Ben M'hadheb
Pageof 2
